• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of relapse: TB treatment outcome associates with differentially culturable counts in sputum samples.

作者信息

Decker J, Mukamolova G V, Garton N, Grint D J, Barer M R

机构信息

Leicester Tuberculosis Research Group, Department of Respiratory Sciences, University of Leicester, Leicester, UK.

National Institute for Health and Care Research Leicester Biomedical Research Centre, Leicester, UK.

出版信息

IJTLD Open. 2025 Aug 13;2(8):493-496. doi: 10.5588/ijtldopen.25.0085. eCollection 2025 Aug.

DOI:10.5588/ijtldopen.25.0085
PMID:40821682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12352955/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b9/12352955/da0211ffe781/ijtldopen25-0085f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b9/12352955/da0211ffe781/ijtldopen25-0085f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b9/12352955/da0211ffe781/ijtldopen25-0085f1.jpg

相似文献

1
Risk of relapse: TB treatment outcome associates with differentially culturable counts in sputum samples.复发风险：结核病治疗结果与痰液样本中可培养细菌数量的差异有关。
IJTLD Open. 2025 Aug 13;2(8):493-496. doi: 10.5588/ijtldopen.25.0085. eCollection 2025 Aug.
2
Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.从痰标本中 DNA 清除情况的纵向分析看，是否真的需要一种新的治疗模式来发现可培养的差异结核分枝杆菌？
BMC Infect Dis. 2018 Jul 3;18(1):293. doi: 10.1186/s12879-018-3213-7.
3
Association of slow recovery of Mycobacterium africanum-infected patients posttreatment with high content of Persister-Like bacilli in pretreatment sputum.非洲分枝杆菌感染患者治疗后恢复缓慢与治疗前痰中高含量类持留菌的关联。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S99-S100. doi: 10.1016/j.ijmyco.2016.09.033. Epub 2016 Nov 11.
4
Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study.粪便Xpert MTB/RIF Ultra检测HIV感染者中结核分枝杆菌的性能：一项多中心前瞻性诊断研究。
Lancet Microbe. 2025 Jul;6(7):101085. doi: 10.1016/j.lanmic.2025.101085. Epub 2025 Apr 4.
5
Differentially culturable in cough-generated aerosols of patients with pulmonary tuberculosis DCTB in cough-generated aerosols.肺结核患者咳嗽产生的气溶胶中可培养性存在差异 肺结核患者咳嗽产生的气溶胶中的可培养性差异
J Med Microbiol. 2025 Jun;74(6). doi: 10.1099/jmm.0.002027.
6
Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy.探究成功抗结核治疗结束后结核患者的非灭菌治愈情况。
Front Cell Infect Microbiol. 2020 Aug 25;10:443. doi: 10.3389/fcimb.2020.00443. eCollection 2020.
7
Assessing the quality of tuberculosis evaluation for children with prolonged cough presenting to routine community health care settings in rural Uganda.评估乌干达农村地区常规社区卫生保健机构中出现长期咳嗽的儿童的结核病评估质量。
PLoS One. 2014 Aug 29;9(8):e105935. doi: 10.1371/journal.pone.0105935. eCollection 2014.
8
Dual-Reporter Mycobacteriophages (Φ2DRMs) Reveal Preexisting Mycobacterium tuberculosis Persistent Cells in Human Sputum.双报告基因分枝杆菌噬菌体（Φ2DRMs）揭示人痰液中预先存在的结核分枝杆菌持留菌。
mBio. 2016 Oct 25;7(5):e01023-16. doi: 10.1128/mBio.01023-16.
9
Repeat detection of Mycobacterium DNA in sputum for the diagnosis of pulmonary tuberculosis.重复检测痰液中的分枝杆菌DNA用于诊断肺结核。
Medicine (Baltimore). 2025 Jun 13;104(24):e42750. doi: 10.1097/MD.0000000000042750.
10
Host and pathogen factors that influence variability of Mycobacterium tuberculosis lipid body content in sputum from patients with tuberculosis: an observational study.宿主和病原体因素对肺结核患者痰液中分枝杆菌脂滴含量变化的影响：一项观察性研究。
Lancet Microbe. 2024 Sep;5(9):100885. doi: 10.1016/S2666-5247(24)00108-3. Epub 2024 Jun 19.

本文引用的文献

1
Host and pathogen factors that influence variability of Mycobacterium tuberculosis lipid body content in sputum from patients with tuberculosis: an observational study.宿主和病原体因素对肺结核患者痰液中分枝杆菌脂滴含量变化的影响：一项观察性研究。
Lancet Microbe. 2024 Sep;5(9):100885. doi: 10.1016/S2666-5247(24)00108-3. Epub 2024 Jun 19.
2
Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response.可培养的结核分枝杆菌作为评估结核病治疗反应的指标。
Front Cell Infect Microbiol. 2023 Jan 12;12:1064148. doi: 10.3389/fcimb.2022.1064148. eCollection 2022.
3
Anti-tuberculosis treatment strategies and drug development: challenges and priorities.
抗结核治疗策略和药物研发：挑战与优先事项。
Nat Rev Microbiol. 2022 Nov;20(11):685-701. doi: 10.1038/s41579-022-00731-y. Epub 2022 Apr 27.
4
Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy.在接受两个月治疗前后，药物敏感或耐药结核病患者痰液中可检测到的结核分枝杆菌的特征。
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0060821. doi: 10.1128/AAC.00608-21.
5
Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy.探究成功抗结核治疗结束后结核患者的非灭菌治愈情况。
Front Cell Infect Microbiol. 2020 Aug 25;10:443. doi: 10.3389/fcimb.2020.00443. eCollection 2020.
6
Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.海地未经治疗的受试者痰液中可检测到的结核分枝杆菌细胞及其在治疗开始后比例的增加。
mBio. 2018 Nov 20;9(6):e02192-18. doi: 10.1128/mBio.02192-18.
7
Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis.肺结核患者痰液中可培养差异结核分枝杆菌的检测与定量分析
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1532-1540. doi: 10.1164/rccm.201604-0769OC.
8
Phenotypically Adapted Mycobacterium tuberculosis Populations from Sputum Are Tolerant to First-Line Drugs.痰液中表型适应性结核分枝杆菌群体对一线药物具有耐受性。
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2476-83. doi: 10.1128/AAC.01380-15. Print 2016 Apr.
9
High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo.高剂量利福平可杀死持留菌，缩短治疗时间，并降低体内外的复发率。
Front Microbiol. 2015 Jun 23;6:641. doi: 10.3389/fmicb.2015.00641. eCollection 2015.
10
Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis.肺结核治疗中细菌清除率的药效学建模及痰液中细菌脂质体的检测以预测和理解治疗结果
Clin Infect Dis. 2015 Jul 1;61(1):1-8. doi: 10.1093/cid/civ195. Epub 2015 Mar 16.